ESR1 and breast cancer: We took advantage of the T47Dco luminal breast cancer cell line, which constitutively express high levels of ER and PR, and allows the study of the unliganded, progesterone-independent regulatory effects of human PRs in ER-positive luminal-like breast cancer without the confounding requirement of estradiol to stimulate PR expression.